# Pharmacokinetic Study of Deferiprone in Paediatric Patients

> **NCT01740713** · PHASE2 · COMPLETED · sponsor: **Consorzio per Valutazioni Biologiche e Farmacologiche** · enrollment: 23 (actual)

## Conditions studied

- Chronic Iron Overload

## Interventions

- **DRUG:** Deferiprone, dose level 1
- **DRUG:** Deferiprone, dose level 2
- **DRUG:** Deferiprone, dose level 3

## Key facts

- **NCT ID:** NCT01740713
- **Lead sponsor:** Consorzio per Valutazioni Biologiche e Farmacologiche
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740713, "Pharmacokinetic Study of Deferiprone in Paediatric Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01740713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*